TAZTIA

Product NDC
62037-699
11-digit product format
620370699
Labeler code
62037
Product ID
62037-699_ef8c3181-0515-4824-98b4-7504dbab84e3
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Diltiazem Hydrochloride
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Labeler
Actavis Pharma, Inc.
Application
ANDA075401
Marketing category
ANDA
Marketing start
2003-04-10
Marketing end
0000-00-00
Substance
DILTIAZEM HYDROCHLORIDE
Active strength
300 mg/1
Pharmacologic classes
Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct62037-699DDiscontinued by firm2026-07-31
excluded packagepackage62037-69962037-699-30DDiscontinued by firm2026-07-31
excluded packagepackage62037-69962037-699-90DDiscontinued by firm2026-07-31

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 5 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A075401-001TAZTIA XTDILTIAZEM HYDROCHLORIDE120MGCAPSULE, EXTENDED RELEASE / ORAL2003-04-10
A075401-002TAZTIA XTDILTIAZEM HYDROCHLORIDE180MGCAPSULE, EXTENDED RELEASE / ORAL2003-04-10
A075401-003TAZTIA XTDILTIAZEM HYDROCHLORIDE240MGCAPSULE, EXTENDED RELEASE / ORAL2003-04-10
A075401-004TAZTIA XTDILTIAZEM HYDROCHLORIDE300MGCAPSULE, EXTENDED RELEASE / ORAL2003-04-10
A075401-005TAZTIA XTDILTIAZEM HYDROCHLORIDE360MGCAPSULE, EXTENDED RELEASE / ORAL2003-04-10

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-01 22:54:322026-06A075401-001TAZTIA XT120MGCAPSULE, EXTENDED RELEASE / ORAL2003-04-10a50c72e98297…
2026-08-01 22:54:322026-06A075401-002TAZTIA XT180MGCAPSULE, EXTENDED RELEASE / ORAL2003-04-10a50c72e98297…
2026-08-01 22:54:322026-06A075401-003TAZTIA XT240MGCAPSULE, EXTENDED RELEASE / ORAL2003-04-10a50c72e98297…
2026-08-01 22:54:322026-06A075401-004TAZTIA XT300MGCAPSULE, EXTENDED RELEASE / ORAL2003-04-10a50c72e98297…
2026-08-01 22:54:322026-06A075401-005TAZTIA XT360MGCAPSULE, EXTENDED RELEASE / ORAL2003-04-10a50c72e98297…

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
62037-699-30EA - Each62037-699241750f5-3fd3-4156-8339-bf405abe63e312012-07-24
62037-699-90EA - Each62037-6992bd97c55-b3a9-48d7-bb6a-eb32098abb2e12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
DILTIAZEM HYDROCHLORIDEACTIVE INGREDIENTOLH94387TETAZTIA XT (DILTIAZEM HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [WATSON PHARMA, INC.]13
DILTIAZEMACTIVE MOIETYEE92BBP03HTAZTIA XT (DILTIAZEM HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [WATSON PHARMA, INC.]13
ALUMINUM OXIDEINACTIVE INGREDIENTLMI26O6933TAZTIA XT (DILTIAZEM HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [WATSON PHARMA, INC.]13
D&C RED NO. 28INACTIVE INGREDIENT767IP0Y5NHTAZTIA XT (DILTIAZEM HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [WATSON PHARMA, INC.]13
D&C YELLOW NO. 10INACTIVE INGREDIENT35SW5USQ3GTAZTIA XT (DILTIAZEM HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [WATSON PHARMA, INC.]13
ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW)INACTIVE INGREDIENTP2OM2Q86BITAZTIA XT (DILTIAZEM HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [WATSON PHARMA, INC.]13
ETHYLCELLULOSE (10 MPA.S)INACTIVE INGREDIENT3DYK7UYZ62TAZTIA XT (DILTIAZEM HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [WATSON PHARMA, INC.]13
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBDTAZTIA XT (DILTIAZEM HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [WATSON PHARMA, INC.]13
FD&C BLUE NO. 2INACTIVE INGREDIENTL06K8R7DQKTAZTIA XT (DILTIAZEM HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [WATSON PHARMA, INC.]13
FD&C RED NO. 40INACTIVE INGREDIENTWZB9127XOATAZTIA XT (DILTIAZEM HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [WATSON PHARMA, INC.]13
FD&C YELLOW NO. 6INACTIVE INGREDIENTH77VEI93A8TAZTIA XT (DILTIAZEM HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [WATSON PHARMA, INC.]13
FERROSOFERRIC OXIDEINACTIVE INGREDIENTXM0M87F357TAZTIA XT (DILTIAZEM HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [WATSON PHARMA, INC.]13
GELATININACTIVE INGREDIENT2G86QN327LTAZTIA XT (DILTIAZEM HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [WATSON PHARMA, INC.]13
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4TAZTIA XT (DILTIAZEM HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [WATSON PHARMA, INC.]13
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30TAZTIA XT (DILTIAZEM HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [WATSON PHARMA, INC.]13
NONOXYNOL-100INACTIVE INGREDIENTA906T4D368TAZTIA XT (DILTIAZEM HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [WATSON PHARMA, INC.]13
POLYSORBATE 80INACTIVE INGREDIENT6OZP39ZG8HTAZTIA XT (DILTIAZEM HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [WATSON PHARMA, INC.]13
POVIDONESINACTIVE INGREDIENTFZ989GH94ETAZTIA XT (DILTIAZEM HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [WATSON PHARMA, INC.]13
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3TAZTIA XT (DILTIAZEM HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [WATSON PHARMA, INC.]13
SHELLACINACTIVE INGREDIENT46N107B71OTAZTIA XT (DILTIAZEM HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [WATSON PHARMA, INC.]13
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJTAZTIA XT (DILTIAZEM HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [WATSON PHARMA, INC.]13
SUCROSEINACTIVE INGREDIENTC151H8M554TAZTIA XT (DILTIAZEM HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [WATSON PHARMA, INC.]13
TALCINACTIVE INGREDIENT7SEV7J4R1UTAZTIA XT (DILTIAZEM HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [WATSON PHARMA, INC.]13
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPTAZTIA XT (DILTIAZEM HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [WATSON PHARMA, INC.]13

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
62037-699-306203706993030 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (62037-699-30) 2003-04-100000-00-00NoNoCurrent
62037-699-906203706999090 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (62037-699-90) 2003-04-100000-00-00NoNoCurrent